How I'm bringing ancient music back to life


What did Palaeolithic pop sound like? Ask the team recreating long-forgotten instruments and the soundscapes they were played in


BONE flutes are the oldest musical instruments discovered so far. The remains of several have been found in European caves also containing Palaeolithic paintings. They date from between 40,000 and 15,000 years ago, a time of enormous creativity, when humans first started to make art and when ritual burials suggest the beginnings of religion or spirituality. As the first hard evidence of human musicality they are fascinating. However, interpreting them has often proved contentious.


Take one of the oldest, the Divje Babe flute. It was found in what is now Slovenia among the remains of Neanderthals, and some believe it was made and used by them. If Neanderthals were musical, they were more similar to us than we might imagine, but that's not the only controversy surrounding this find. Some argue ...


To continue reading this article, subscribe to receive access to all of newscientist.com, including 20 years of archive content.



Warming world means a hike in US lightning strikes



Golfers beware. Expect more lightning bolts as the world warms up.


We already know that climate change is increasing the likelihood of storms, tornadoes and heatwaves. Now, a model of how climate change will affect lightning patterns in the US predicts that for every 1°C of global warming, lightning strikes will increase by 12 per cent.


Currently, there are about 25 million lightning strikes each year in the US. These ignite half of the wildfires that break out and kill approximately 100 people every year. More lightning potentially means more wildfires, and more strikes on people and buildings.


Researchers led by David Romps at the University of California, Berkeley, applied their lightning-analysis method to 11 standard projections of climate change, which range in predicted global warming from 2.5°C to 5°C.


Overall, they forecast that lightning bolts will increase in number by 50 per cent over the next century. "For every two lightning strikes in 2000, there will be three in 2100," says Romps.


At present, meteorologists work out how likely lightning strikes will be from the depth of clouds – the deeper the clouds, the more likely they will generate lightning.


Hot and humid


Romps's team relied instead on standard forecasts of rainfall per unit of area, and how energetic a storm will potentially be, which can be worked out from temperature and humidity measurements taken by weather balloons.


By knowing how much water is in the clouds and how much energy is available, Romps says his model can accurately predict how many lightning bolts will get generated. Typically, he says, about 1 per cent of the potential energy picked up by water gets converted to lightning, so by knowing how much water and energy is present, the team can work out how much lightning will form.


They tested the model using real weather data from 2011, and compared the results with the data on every lightning strike in the US, collected by the National Lightning Detection Network. In simple terms, they found that it retrospectively correctly accounted for 77 per cent of that year's ground strikes (see video, above, for 2011's lightning strikes). "When I saw that result, I thought it was too good to be true," says Romps.


Bolts from the blue


Having validated it against past weather, Romps applied it to the 11 climate models. The resulting prediction estimated that for every 1°C rise in global temperatures, there would be a rise in lightning strikes of 12 per cent, on average. Across the 11 models the projections for increases in lightning ranged from 3.4 per cent per 1°C to 17.6 per 1°C in the worst-case scenario. In this worst-case scenario, with 5°C of global warming, lightning strikes more than doubled by the year 2100.


The new model "probably yields a better estimate than previous methods", says William Beasley at the University of Oklahoma in Norman. He adds that the precision might be improved further if the model could include data on ice particles in clouds – in addition to liquid water – plus information on bolts that occur only in clouds, as these are five to 10 times more frequent than ground strikes.


Romps's team aims to work out how the additional lightning will be distributed – whether it will increase where storms are already most common, or spread to areas relatively free of lightning at present. "At this point, we don't know, but the distribution of lightning strikes is important for predicting changes to wildfire frequency," Romps notes.


He is optimistic that the same model could be applied to other regions of the world.


Journal reference: Science, DOI: 10.1126/science.1259100


If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



Infanticide drives female promiscuity and big balls


Great balls of furriness! Among mammals, large testicles are a sign of a species with a history of males that have no qualms about killing the babies of their competitors.


A study of more than 200 mammals from mice to lions reveals that in species where infanticide is frequent, females make it hard for males to know which baby to kill by mating with lots of different males during the same season. The study also finds that the ancestor to all great apes - including humans - probably committed infanticide.


Infanticide is widespread among mammals. Lions do it, chimps do it, many adorable-looking lemurs do it. Why? A leading theory is that males kill infants sired by other males because it frees up females to have their own offspring, perpetuating their own genes rather than those of their competitors.


To test this in a large evolutionary model, Dieter Lukas of the University of Cambridge and Elise Huchard of the University of Montpellier in France drew up a huge database of behaviours found in over 200 species of mammals and mapped them onto the mammalian family tree.


The pair confirmed that infanticide was most frequent in species that lived in groups where a few dominant males monopolise the right to mate with the clan's females, and their tenure as top sperm donor is short.


"The males don't manage to stay dominant for very long, so when they can mate with the females, they need to do it as quickly as possible," explains Huchard. "It's not in their interest to wait for the females to finish rearing infants." Killing babies, in this instance, is an efficient way to fast-track nursing females back to fertility.


"The study confirms that infanticide isn't some curious thing caused by humans encroaching on animal territory, it is a male tactic to improve their mating opportunities," says Kit Opie of University College London.


The tree also revealed that infanticide was probably prevalent in the common ancestor of all great apes. The behaviour lives on in chimps and gorillas, although bonobos, orang-utans and - thankfully - humans have lost the trait.


Promiscuous response


No animal likes having its baby killed, so what's the defence? A recent study of primates found that they evolved monogamy early as a response to infanticide.


But in the larger mammalian tree, Lukas and Huchard found hints of another trick, in the form of a very strong link between infanticide and testicle size. Males belonging to species that commit infanticide frequently evolve large balls.


"It has long been known that testes size reflects the number of sex partners that females have," says Huchard. The large testicular size of males in species that commit infanticide suggests that females are more promiscuous, mating with multiple males before giving birth to their offspring.


What's more, by studying their evolutionary tree, the team found that large testes tended to evolve after infanticide had appeared, and continued to become larger over time. This suggests that when male mammals begin to kill infants, females respond by mating with lots of different males during the same season, forcing males into a sperm competition. Males grow larger testes to produce more sperm, but also don't know which infant is theirs. As a result, infanticide becomes counterproductive - there is always a risk they might wipe out their own gene pool.


And it's a response that works. Huchard and Lukas found that infanticide can be lost in species where the testes have grown large. Bonobos, for instance, appear to have lost infanticide since they diverged from chimps.


Journal reference: Science, DOI: 10.1126/science.1257226


If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



Cells act like old tape recorders to monitor health


They're the world's smallest documentary makers. E. coli bacteria have had their DNA hacked so they can store memories of their cellular environment. And they do it in much the same way as an analogue tape recorder. Other more complicated cells should be capable of the feat too, which could pave the way for cellular biographers that can be inserted into our bodies for the inside scoop on our health.


E. coli may be one of the most widely used microbes in scientific research, but there are still aspects of its biology that are mysterious. "There are these DNA sequences called retrons that were discovered 30 years ago – but there's still a lot of controversy over what they actually do," says Timothy Lu at the Massachusetts Institute of Technology.


What we do know is that the retrons carry the genetic code for enzymes that generate new strands of DNA. These strands can then insert themselves into the cell's genome. Lu and his MIT colleague Fahim Farzadfard realised that they could manipulate these retrons so that, when the E. coli is exposed to a particular chemical – or some other input like bright light – it inserts a new chunk of DNA into a specific site in the genome. That DNA chunk is then effectively a "memory" of the experience.


Crowdsourced memories


Each of the E. coli cells records a personal account of its experiences. That could be useful, but it's when whole populations of cells record their experiences that the system becomes really powerful.


Lu and Farzadfard engineered the retrons to be only partially efficient, so that when a population of E. coli is exposed to an input, like a light signal, only a few cells will instantly record a memory of the event.


As time goes by, more of the cells will respond to the input and record the memory. By calculating at a certain point how many of the cells carry the memory, it's possible to work out either the input's strength, or the length of exposure.


"Imagine having 1000 humans all exposed to sunlight," says Lu. "Some proportion will develop a mole on skin from over-exposure. With more exposure, an increasing number of people will develop the mole. So by counting the number of people with moles you can back-calculate how intense or how long the exposure was."


Play back memories


"That's the crux of it," says Cameron Myhrvold at Harvard University's Wyss Institute for Biologically Inspired Engineering, who was not involved in the research. "You can encode extra information because it's a signal that accumulates over time rather than an all-or-nothing switch." In other words, its analogue rather than digital.


"We think this is going to be very useful in monitoring applications," says Lu. The retrons are known to function in animal cells, he says, so if some of our cells were engineered to record the conditions they are exposed to, they could later be extracted and their DNA sequenced to play back the memories.


That kind of cellular monitoring is already possible with some microscopy techniques, but Lu says that these techniques require researchers to keep a constant eye on the cells. With his method, cellular environments could be seeded with cells to remotely record events in much the same way that forests are wired up with camera traps to remotely track wildlife.


Monitoring disease


For example, modified gut cells could be used to track the progress of conditions like irritable bowel syndrome, or modified brain cells could help establish the nature of individual cellular connections within neural networks, says Lu.


In principle, the cellular system could be used to monitor the spread of disease, such as the growth and spread of cancers, perhaps by responding to the cellular signals generated by cancer cells, although Lu says additional development will be needed before that can be demonstrated.


Although an analogue system allows you to record more nuanced information, Myhrvold says that this is also a potential weakness. It means it works best when there is a large population of cellular recorders, so might not work so well for monitoring environments that contain relatively small numbers of cells to begin with, he says. That's an important point, agrees Lu, and one he's working on.


Myhrvold also says that retrons might mutate and malfunction in some more challenging cellular environments, which could compromise their ability to record cellular events. This is a problem that his Harvard colleague, Pamela Silver, addressed earlier this year by inserting a responsive genetic switch into E. coli that is so resistant to mutation that it is stable even in the hostile environment of the mammalian gut.


Journal reference: Science, DOI: 10.1126/science.1256272


If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



Ebola blood and drug trials to start in December


Drugs for Ebola just moved a step closer. Two antiviral drugs will finally be tested amid the Ebola epidemic in West Africa, starting next month, Médecins sans Frontières announced today. Blood from survivors of the disease will also be given to people infected with Ebola to see whether the antibodies it contains help them recover.


All of the trials will abandon the classic design in which people given the treatment are compared to people given a placebo.


Officials at the World Health Organization and drug regulators had argued that such placebo-controlled trials were necessary to see quickly whether the drugs work. But investigators have concerns about whether it is ethical, or even possible, to randomly give people with Ebola a placebo in the midst of an epidemic that kills 70 per cent of those infected.


A network of social scientists and anthropologists, organised by the London School of Hygiene and Tropical Medicine, is advising the trials teams on communicating with the community, in an effort to prevent the kind of rumours and misconceptions that stymied early efforts to control the virus.


No placebo


According to Médecins sans Frontières, trials of two antiviral drugs will involve simply giving 100 to 200 people the drug, then following them to see how many survive another two weeks.


The University of Oxford is running one of the trials – investigating brincidofovir, an antiviral owned by the US firm Chimerix, which was developed to kill viruses that affect people with weakened immune systems. It has been shown to kill Ebola in culture and in small animal tests. The French national institute for medical research, INSERM, is running the other, trialling favipiravir, an anti-flu drug shown to cure Ebola in monkeys and owned by Japan's Fujifilm.


The group running the favipiravir trial, led by Denis Morvy of the University of Bordeaux, will test the drug in 200 people. Sixty of those will have developed symptoms just two days prior to receiving treatment.


Getting the timing right is crucial because both drugs work by stopping the virus making copies of itself. This means that they may only be useful in the early stages of the disease. In the more advanced stages the symptoms are actually caused by the infected person's own runaway immune response; at that point stopping viral replication doesn't help.


Peter Horby of the University of Oxford, who heads the team running the bricidofovir trial, argued in a paper last month that placebo controlled trials were neither ethical nor practical in an Ebola emergency. The trial about to start will be more like a triage, he says, allowing investigators to decide quickly which drugs clearly work and which don't. Moreover, in most clinical trials investigators wait until all the information is in before evaluating it, but these trials will use novel statistical methods to constantly evaluate data, aiming to spot early winners or losers.


Flexible design


If death rates remain above 50 per cent, the drug will be deemed a failure and the trial will be discontinued, to start testing another antiviral, Horby told New Scientist. If survival at two weeks is above 80 per cent, the trial will also be stopped on the recommendation that the drug move to larger-scale trials for further development. Anything in between, he says, will require more careful testing.


"I would rather do a trial that I know can deliver a clear result, than try to do something that might turn out to be impossible", he says. He believes a randomised controlled trial – the usual gold standard trial design – is too difficult given the shortage of healthcare workers.


Johan van Griensven of the Antwerp Institute of Tropical Medicine in Belgium, where Ebola was discovered, will be testing whether blood from Ebola survivors boosts 100 people's odds of surviving two weeks. The trial will switch to plasma – blood with the cells removed – when staff and equipment to provide it are in place. In 1995 seven of eight people infected with Ebola survived after being given such "convalescent plasma" during an outbreak in the Democratic Republic of Congo, but critics point out that they were already past the peak of the disease and may have survived anyway.


It has taken several months to settle all the legal issues and decide on the experimental design. Getting approvals from regulators in the countries affected and those running the trials is still on-going. The blood and favipiravir trials will take place in Guinea. The site of the bricidofovir trials has not yet been settled. All the same, results are expected by March, or earlier if effects are good.



Vaccines gearing up


Antiviral drugs aren't the only hope against Ebola. At the annual meeting of the American Society for Tropical Medicine in New Orleans last week, regulators from the US Food and Drug Administration outlined trials for two Ebola vaccines for healthcare workers. Trials for one of them, owned by the British firm GSK, could start as early as December. Trials could start in January for the other, from a small US firm called NewLink.


The GSK vaccine will be tested in Liberia using a classic placebo-controlled design, in which some participants randomly get another antiviral vaccine – one that doesn't act on Ebola – to serve as a placebo. The other will be tested in Sierra Leone using a design in which groups given the vaccine are compared to groups not given any type of vaccine – so no use of placebo.


But Armand Sprecher of Médecins sans Frontières says it is too late for vaccines to have much effect on the Ebola epidemic. He hopes vaccinating healthcare workers will allow them to come back to work.


He says Médecins sans Frontières suspects more people have died since the Ebola epidemic intensified in March because of the collapse of healthcare systems in the three worst-affected countries than have died of Ebola. The aid agency is conducting a study to find out.



If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



Philae has landed – first image from the surface


The European Space Agency's Philae lander performed not one, not two but three historic landings yesterday. That's according to data downloaded overnight from the spacecraft that confirms Philae bounced twice as it settled down on to comet 67P/Churyumov-Gerasimenko.


ESA has just released Philae's first photo from the surface, later than expected due to landing complications. Readings from the probe suggest Philae initially touched down at 1533 GMT yesterday, with mission managers at the European Space Operations Centre in Darmstadt, Germany, receiving the confirmation signal on Earth around half an hour later. But data from the probe's magnetometer shows Philae also landed at 1726 GMT and 1733 GMT, bouncing off the surface due to the comet's weak gravity, around 10,000th that of Earth's.


That initial bounce, almost 2 hours long, could have sent Philae flying as high as 1 kilometre above the comet's surface. It has also left the probe in a precarious position. Although Philae is now stable and sitting on the surface, a fault with its harpoons means it is not firmly attached to the comet. It may also be angled in a way that reduces the amount of sunlight that can reach its solar panels.


These problems mean ESA managers have ruled out today's planned drilling into the surface, as it could disrupt the probe since it doesn't have a proper anchor. But the data connection issues they were experiencing yesterday have now been solved, allowing them to grab images from the probe.


The just-released image is actually two pictures from Philae's CIVA camera. ESA has downloaded seven images, giving a full panorama, but these won't be released until later. From the image released now, it isn't yet clear if Philae is flat on the surface of 67P. "It could be angled, it could be on the ground," says ESA senior scientist Mark McCaughrean. "It will become more apparent over time."


If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



My thinking chip paves the way for brain-like computers


What does it mean to build a computer that works like the human brain?

We are trying to approximate the brain's essence within today's silicon technology. We're not looking to model the human brain anatomically, but to build a computer that mimics its abilities for sensation, perception, interaction and cognition while rivalling its low power consumption and compact size.


Current computers are very logical, sequential and quantitative. They are based on a 70-year-old architecture that separates memory from processing, and works in a step-by-step fashion, executing a series of pre-written "if X then do Y" equations. They are fast number crunchers and can process lots of data, but they really don't think. That's what we are trying to change.


At the heart of this is a new kind of chip. How does it work?

Conventional computers consume a lot of energy moving data to and from memory. But in the brain, memory ...


To continue reading this article, subscribe to receive access to all of newscientist.com, including 20 years of archive content.



The lifelong cost of burying our traumatic experiences



Past trauma can mean not feeling fully alive in the present (Image: Stanley Greene/Noor/eyevine)


The trauma caused by childhood neglect, sexual or domestic abuse and war wreaks havoc in our bodies, says Bessel van der Kolk in The Body Keeps the Score


WHAT has killed more Americans since 2001 than the Afghanistan and Iraq wars? And which serious health issue is twice as likely to affect US women as breast cancer?


The answer, claims psychiatrist Bessel van der Kolk, lies in what we now understand about trauma and its effects. In his disturbing book, The Body Keeps the Score, he explains how trauma and its resulting stress harms us through physiological changes to body and brain, and that those harms can persist throughout life. Excess stress can predispose us to everything from diabetes to heart disease, maybe even cancer.


Take his two examples. The number of Americans killed by family members exceeds the number that country lost in both wars. But it doesn't stop there. Imagine the fallout for all who witnessed the murder or likely violence in the years preceding it. And women have double the risk of domestic violence – with the health consequences that brings – as they do of breast cancer.


Van der Kolk draws on 30 years of experience to argue powerfully that trauma is one of the West's most urgent public health issues. The list of its effects is long: on mental and physical health, employment, education, crime, relationships, domestic or family abuse, alcoholism, drug addiction. "We all want to live in a world that is safe, manageable... predictable, and victims remind us that this is not always the case," says van der Kolk. When no one wants to hear about a person's trauma, it finds a way to manifest in their body.


And it is not only extreme experiences that linger. Family disturbance or generalised neglect can wire children to be on high alert, their stressed bodies tuned to fight or flight. Or they may be so "numbed out" by keeping demons at bay they can't engage with life's pleasures or protect themselves from future trauma. Even parents who don't attune with their children can do untold damage, van der Kolk argues.


He makes it clear why it's so important: help parents with their problems, deprivation or social isolation, and you help their kids. "If your parents' faces never lit up when they looked at you, it's hard to know what it feels like to be loved and cherished," he says. Neglect creates mental maps used by children, and their adult selves, to survive. These maps skew their view of themselves and the world.


The book has gut-wrenching stories: about Vietnam veterans who committed war atrocities, incest survivors, broken adults that were terrorised as children or shunted between foster homes. Van der Kolk draws on hundreds of studies to back up his claim that "the body keeps the score".


We meet a woman who had suppressed the memory of being raped at age 8 by her father, but when she ferociously attacked a new partner for no reason, she signed up for therapy with van der Kolk. Soon after, her eyesight started to fail: an autoimmune disease was eroding her retina. In a study, his team found that female incest survivors had abnormalities in the ratios of immune cells, compared with untraumatised women, exposing them to autoimmune diseases.


In terms of treatments, van der Kolk argues that "integrating" trauma by turning it into a bad memory, rather than reliving it, in therapy, may be key to recovering from trauma. And he criticises dealing with symptoms rather than causes. He has scary stats: half a million US children and teens take antipsychotic drugs, while privately insured 2 to 5-year-olds on antipsychotics have doubled between 2000 and 2007.


Packed with science and human stories, the book is an intense read that can get technical. Stay with it, though: van der Kolk has a lot to say, and the struggle and resilience of his patients is very moving.


This article appeared in print under the headline "Everybody hurts"


Shaoni Bhattacharya is a consultant for New Scientist


Issue 2994 of New Scientist magazine


  • New Scientist

  • Not just a website!

  • Subscribe to New Scientist and get:

  • New Scientist magazine delivered every week

  • Unlimited online access to articles from over 500 back issues

  • Subscribe Now and Save




If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



Obama shocks cable firms with call for net neutrality


The open internet just got some serious backing. On Monday, US president Barack Obama asked the Federal Communications Commission to adopt rules to preserve net neutrality, the idea that all data on the internet should be treated equally. It would prevent internet service providers (ISPs) charging for preferential access to their networks.


The rules would see ISPs such as Comcast reclassified as public utilities, forced to provide access to the internet like other utilities provide electricity or water. Phone companies already have this classification, but ISPs have been "information services" since the late 90s, subject to the same loose regulation as internet companies like Netflix and Facebook.


If brought in, the rules would stop ISPs speeding up, slowing down or blocking connections to any online service. They would not be allowed to offer prioritisation of traffic in exchange for money.


In his statement, Obama asked the FCC to "answer the call of almost 4 million public comments, and implement the strongest possible rules to protect net neutrality."


Specifically, Obama urged the FCC to adopt at least four foundation measures that should go a long way towards protecting internet users from actions designed only to protect the vested interests of ISPs.


No slow lane


First, ISPs must end the practice of blocking access to websites that compete with services they offer - for instance, a cable company with its own bundle of pay-TV movie channels might block access to the Netflix movie streaming service.


Second, ISPs should not slow down – or "throttle" – the bit rate at which competing services are accessed merely to give consumers a poorer experience of that service, where juddery imagery and frequent buffering could ruin the video, for example.


In addition, Obama says ISPs need to be transparent about the technology they use to physically connect homes to the internet - because they could evade rules on throttling by diverting rival services through substandard servers that have a similar effect.


Finally, no service should be permanently stuck in a "slow lane" simply unless users pay a fee for priority access to better download speeds. "That kind of gatekeeping would undermine the level playing field essential to the internet's growth," says Obama.


We vs ISP


The reaction from the US telecoms sector has been swift, with Verizon, for instance, slating the plan as something akin to "1930s-era utility regulation" - adding that it will "not stand up in court".


The issue will be decided in the US courts, predicts William Webb, former technical director of UK telecoms regulator Ofcom, and now president of the Institute of Engineering and Technology in London.


"It is very hard to see how Obama's plan will pan out because it depends entirely on the decisions of the US courts. While he has popular opinion behind him, the cable companies - who have cornered the market in internet provision in the US - are every strong and powerful lobbyists."


If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.



Troublesome sunspot spins out of view


(Image: Alan Friedman)


OUT, damned spot! The largest sunspot in 25 years is about to slide off the face of the sun and out of sight. The catchily named spot – Active Region 12192 – has been a wild one, spawning six large solar flares that knocked out radio communications across swathes of the planet last week. If it is still active by the time it rotates back to our side of the sun, it will thankfully be a shadow of its former self.


In this image, taken at the shortest wavelengths the human eye can see, near the ultraviolet end of the spectrum, AR 12192 is dark because it is relatively cool. It's a mere 3000 °C, compared with the 5500 °C blaze of the surrounding photosphere. Powerful magnetic fields twisted beneath the sun's surface stymie the star's normal convective heating.


"This time of year I have to wait for the sun to get up past a whole bunch of cable TV wires and electrical poles, so it's 11 o'clock before I can see it," says astrophotographer Alan Friedman, based in Buffalo, New York. "Makes it hard to have a day job too."


Friedman used a filter made of calcium and potassium to block out a large component of the sun's light, making it resemble a ghostly, volcanic ping pong ball, or perhaps a human egg cell.


For Friedman, photos are the only way to reveal this view of the sun: "When I look through the telescope I can't see a thing at that wavelength. As your eyes get older and more yellow they block the higher wavelengths. But the camera can still see well."


This article appeared in print under the headline "Sunny and flare"


Issue 2994 of New Scientist magazine


  • Subscribe to New Scientist and you'll get:

  • New Scientist magazine delivered every week

  • Unlimited access to all New Scientist online content -

    a benefit only available to subscribers

  • Great savings from the normal price

  • Subscribe now!




If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.